PriceTargets.com logo

Teladoc Health - TDOC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $11.26
  • Forecasted Upside: 45.03%
  • Number of Analysts: 18
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$7.77 As of 04/1/2025 04:59 PM ET
▼ -0.193 (-2.42%)

This chart shows the closing price for TDOC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
FebMar$7.77Closing price on 04/01/25:
Get New Teladoc Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TDOC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TDOC

Analyst Price Target is $11.26
▲ +45.03% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Teladoc Health in the last 3 months. The average price target is $11.26, with a high forecast of $17.00 and a low forecast of $8.00. The average price target represents a 45.03% upside from the last price of $7.77.

This chart shows the closing price for TDOC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/244/254/26$4.75$7.81$11$14$17Closing price on 04/01/25: $7.77High$17.00Average$11.26Low$8.00




Current Consensus is Hold

The current consensus among 18 contributing investment analysts is to hold stock in Teladoc Health. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
10/9/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
1/7/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
4/6/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 12 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 14 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 14 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
Ratings as of
3/2/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2025

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/3/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$16.00 ➝ $13.00
2/27/2025Piper SandlerLower TargetOverweight ➝ Overweight$13.00 ➝ $12.00
2/27/2025Needham & Company LLCReiterated RatingHold ➝ Hold
2/18/2025The Goldman Sachs GroupBoost TargetBuy ➝ Buy$14.00 ➝ $16.00
2/12/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$11.50 ➝ $13.50
2/6/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$10.50 ➝ $11.50
1/24/2025Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$11.00 ➝ $12.00
1/24/2025OppenheimerLower TargetOutperform ➝ Outperform$14.00 ➝ $12.00
12/4/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$11.00 ➝ $13.00
11/15/2024The Goldman Sachs GroupInitiated CoverageBuy$14.00
11/1/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$10.00 ➝ $12.00
10/31/2024TD CowenLower TargetHold ➝ Hold$9.00 ➝ $8.00
10/31/2024BarclaysBoost TargetOverweight ➝ Overweight$10.00 ➝ $12.00
10/9/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$9.00 ➝ $10.00
10/8/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$8.00 ➝ $9.00
9/17/2024Jefferies Financial GroupBoost TargetHold ➝ Hold$8.00 ➝ $10.00
8/26/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$16.00 ➝ $9.00
8/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$10.00 ➝ $10.00
8/6/2024Piper SandlerLower TargetOverweight ➝ Overweight$25.00 ➝ $10.00
8/2/2024Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$15.00 ➝ $10.00
8/2/2024Truist FinancialLower TargetHold ➝ Hold$15.00 ➝ $10.00
8/1/2024Needham & Company LLCReiterated RatingHold
8/1/2024TD CowenLower TargetHold ➝ Hold$15.00 ➝ $9.00
8/1/2024BarclaysLower TargetOverweight ➝ Overweight$20.00 ➝ $10.00
8/1/2024DA DavidsonLower TargetNeutral ➝ Neutral$12.00 ➝ $8.00
8/1/2024Stifel NicolausLower TargetHold ➝ Hold$16.00 ➝ $9.00
8/1/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$25.00 ➝ $17.00
8/1/2024OppenheimerLower TargetOutperform ➝ Outperform$21.00 ➝ $17.00
7/9/2024Evercore ISILower TargetIn-Line ➝ In-Line$14.00 ➝ $10.00
5/21/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$19.00 ➝ $16.00
5/14/2024Bank of AmericaLower TargetNeutral ➝ Neutral$16.50 ➝ $13.50
4/29/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$17.00 ➝ $15.00
4/26/2024OppenheimerLower TargetOutperform ➝ Outperform$26.00 ➝ $21.00
4/26/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$25.00 ➝ $18.00
4/26/2024Evercore ISILower TargetIn-Line ➝ In-Line$15.00 ➝ $14.00
4/26/2024TD CowenLower TargetHold ➝ Hold$16.00 ➝ $15.00
4/26/2024Stifel NicolausLower TargetHold ➝ Hold$21.00 ➝ $16.00
4/26/2024BarclaysLower TargetOverweight ➝ Overweight$25.00 ➝ $20.00
4/26/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$28.00 ➝ $25.00
4/26/2024Needham & Company LLCReiterated RatingHold
4/5/2024Needham & Company LLCReiterated RatingHold
3/6/2024Truist FinancialLower TargetHold ➝ Hold$23.00 ➝ $17.00
2/29/2024Cantor FitzgeraldInitiated CoverageOverweight$22.00
2/26/2024Leerink PartnrsReiterated RatingMarket Perform
2/26/2024Leerink PartnersInitiated CoverageMarket Perform$17.00
2/21/2024DA DavidsonLower TargetNeutral ➝ Neutral$22.00 ➝ $18.00
2/21/2024CitigroupLower TargetNeutral ➝ Neutral$21.00 ➝ $19.00
2/21/2024BarclaysLower TargetOverweight ➝ Overweight$26.00 ➝ $25.00
2/21/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$30.00 ➝ $25.00
2/21/2024Piper SandlerLower TargetOverweight ➝ Overweight$30.00 ➝ $25.00
2/21/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$34.00 ➝ $28.00
1/17/2024DA DavidsonDowngradeBuy ➝ Neutral$33.00 ➝ $22.00
1/3/2024BarclaysInitiated CoverageOverweight$26.00
11/17/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$33.00 ➝ $19.00
10/25/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$35.00 ➝ $30.00
10/25/2023OppenheimerLower TargetOutperform ➝ Outperform$35.00 ➝ $26.00
10/20/2023CitigroupLower TargetNeutral ➝ Neutral$29.00 ➝ $21.00
10/11/2023Evercore ISILower Target$25.00 ➝ $19.00
9/25/2023Truist FinancialReiterated RatingHold ➝ Hold$28.00
7/26/2023CitigroupLower Target$31.00 ➝ $29.00
4/28/2023888Reiterated RatingMaintains
4/28/2023Deutsche Bank AktiengesellschaftBoost Target$27.00 ➝ $29.00
4/27/2023VNET GroupReiterated RatingMaintains
4/27/202358.comReiterated RatingMaintains
4/27/2023BarclaysBoost Target$28.00 ➝ $29.00
4/11/2023StephensInitiated CoverageEqual Weight$25.00
3/10/2023Credit Suisse GroupLower TargetNeutral$30.00 ➝ $27.00
3/6/2023Canaccord Genuity GroupLower TargetBuy$40.00 ➝ $36.00
3/6/2023Wells Fargo & CompanyLower TargetEqual Weight$28.00 ➝ $23.00
2/28/2023CitigroupLower TargetNeutral$33.00 ➝ $30.00
2/27/2023JPMorgan Chase & Co.Lower TargetNeutral$35.00 ➝ $33.00
2/27/2023Deutsche Bank AktiengesellschaftLower TargetHold$31.00 ➝ $27.00
2/23/2023OppenheimerLower TargetOutperform$37.00 ➝ $35.00
2/23/2023Royal Bank of CanadaReiterated RatingOutperform$35.00
2/23/2023Leerink PartnersUpgradeMarket Perform ➝ Outperform$34.00
2/23/2023SVB SecuritiesUpgradeMarket Perform ➝ Outperform$34.00
1/19/2023OppenheimerLower TargetOutperform$45.00 ➝ $37.00
1/18/2023BarclaysLower TargetEqual Weight$32.00 ➝ $28.00
12/13/2022CitigroupLower TargetNeutral$36.00 ➝ $33.00
10/31/2022Credit Suisse GroupLower TargetNeutral$35.00 ➝ $30.00
10/28/2022Canaccord Genuity GroupLower Target$45.00 ➝ $43.00
10/27/2022CowenLower Target$30.00
10/27/2022OppenheimerLower Target$55.00 ➝ $45.00
10/27/2022CitigroupLower TargetNeutral$38.00 ➝ $36.00
10/27/2022BarclaysLower TargetEqual Weight$33.00 ➝ $32.00
10/25/2022DA DavidsonLower TargetBuy$45.00 ➝ $40.00
10/24/2022GuggenheimUpgradeSell ➝ Neutral
10/21/2022Truist FinancialLower TargetHold$35.00 ➝ $29.00
10/11/2022BarclaysLower TargetEqual Weight$40.00 ➝ $33.00
9/28/2022Royal Bank of CanadaLower Target$53.00 ➝ $35.00
9/27/2022Deutsche Bank AktiengesellschaftLower TargetHold$34.00 ➝ $31.00
9/15/2022KeyCorpInitiated CoverageSector Weight ➝ Sector Weight
9/7/2022Truist FinancialInitiated CoverageHold$35.00
8/17/2022GuggenheimDowngradeNeutral ➝ Sell$25.00
8/12/2022DA DavidsonInitiated CoverageBuy$45.00
8/2/2022CowenDowngradeOutperform ➝ Market Perform$58.00 ➝ $34.00
8/2/2022Berenberg BankDowngradeBuy ➝ Hold$42.00 ➝ $35.00
8/2/2022CowenDowngradeOutperform ➝ Market Perform$58.00 ➝ $34.00
7/29/2022Deutsche Bank AktiengesellschaftLower Target$44.00 ➝ $34.00
7/28/2022Leerink PartnersLower TargetMarket Perform$35.00 ➝ $34.00
7/28/2022Canaccord Genuity GroupLower Target$50.00 ➝ $45.00
7/28/2022Stifel NicolausLower Target$36.00 ➝ $30.00
7/28/2022Needham & Company LLCDowngradeBuy ➝ Hold
7/28/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00 ➝ $36.00
7/28/2022CitigroupLower Target$43.00 ➝ $38.00
7/28/2022OppenheimerLower TargetOutperform$65.00 ➝ $55.00
7/28/2022Piper SandlerLower TargetOverweight$42.00 ➝ $40.00
7/20/2022BarclaysLower TargetEqual Weight$45.00 ➝ $42.00
7/6/2022Bank of AmericaBoost TargetNeutral$36.00 ➝ $42.00
6/29/2022Stifel NicolausLower TargetHold$45.00 ➝ $36.00
5/26/2022The Goldman Sachs GroupLower TargetBuy$77.00 ➝ $55.00
5/13/2022Piper SandlerBoost Target$21.00 ➝ $42.00
5/5/2022ArgusDowngradeBuy ➝ Hold
4/28/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
4/28/2022Leerink PartnersDowngradeOutperform ➝ Market Perform
4/28/2022Craig HallumLower Target$67.00 ➝ $30.00
4/28/2022Canaccord Genuity GroupLower Target$112.00 ➝ $50.00
4/28/2022BarclaysLower Target$77.00 ➝ $45.00
4/28/2022OppenheimerLower Target$130.00 ➝ $65.00
4/28/2022Needham & Company LLCLower Target$100.00 ➝ $48.00
4/28/2022Deutsche Bank AktiengesellschaftLower Target$78.00 ➝ $44.00
4/28/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$114.00 ➝ $35.00
4/28/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$104.00 ➝ $40.00
4/28/2022CitigroupDowngradeBuy ➝ Neutral$115.00 ➝ $43.00
4/28/2022GuggenheimDowngradeBuy ➝ Neutral
4/28/2022William BlairDowngradeOutperform ➝ Market Perform
4/27/2022Robert W. BairdLower Target$72.00 ➝ $64.00
4/12/2022Royal Bank of CanadaLower TargetOutperform$215.00 ➝ $120.00
4/6/2022GuggenheimInitiated CoverageBuy$96.00
3/17/2022CitigroupLower Target$132.00 ➝ $115.00
3/8/2022Piper SandlerLower TargetOverweight$108.00 ➝ $104.00
3/8/2022UBS GroupLower TargetNeutral$130.00 ➝ $72.00
3/3/2022ArgusUpgradeHold ➝ Buy$95.00
2/25/2022Credit Suisse GroupLower TargetOutperform$151.00 ➝ $114.00
2/24/2022Deutsche Bank AktiengesellschaftLower TargetHold$81.00 ➝ $78.00
2/23/2022Evercore ISILower TargetInline$90.00 ➝ $70.00
2/23/2022The Goldman Sachs GroupLower TargetBuy$121.00 ➝ $120.00
2/23/2022Bank of AmericaLower TargetNeutral$80.00 ➝ $75.00
2/23/2022Canaccord Genuity GroupLower Target$160.00 ➝ $112.00
2/23/2022Stifel NicolausLower TargetHold$83.00 ➝ $74.00
2/23/2022Craig HallumLower TargetHold$82.00 ➝ $67.00
2/23/2022OppenheimerLower TargetOutperform$160.00 ➝ $130.00
2/23/2022Needham & Company LLCLower TargetBuy$170.00 ➝ $100.00
2/23/2022BarclaysLower TargetEqual Weight$95.00 ➝ $77.00
2/23/2022Robert W. BairdLower Target$110.00 ➝ $72.00
2/23/2022JPMorgan Chase & Co.Lower TargetOverweight$208.00 ➝ $125.00
2/23/2022Leerink PartnersLower TargetOutperform$193.00 ➝ $161.00
2/23/2022KeyCorpLower TargetOverweight$180.00 ➝ $100.00
2/11/2022The Goldman Sachs GroupInitiated CoverageBuy$121.00
2/8/2022Piper SandlerLower TargetOverweight$118.00 ➝ $108.00
2/7/2022Jefferies Financial GroupLower TargetHold$113.00 ➝ $82.00
1/25/2022Deutsche Bank AktiengesellschaftLower TargetHold$163.00 ➝ $81.00
1/11/2022Piper SandlerLower Target$183.00 ➝ $118.00
11/22/2021Berenberg BankReiterated RatingBuy
11/22/2021Stifel NicolausLower TargetHold$153.00 ➝ $135.00
11/22/2021BTIG ResearchDowngradeBuy ➝ Neutral
11/19/2021Credit Suisse GroupLower TargetOutperform$208.00 ➝ $207.00
11/19/2021StephensLower TargetEqual Weight$140.00 ➝ $135.00
11/19/2021OppenheimerLower TargetOutperform$200.00 ➝ $185.00
11/19/2021CitigroupLower TargetBuy$190.00 ➝ $175.00
11/19/2021Leerink PartnersLower TargetOutperform$205.00 ➝ $193.00
11/15/2021Royal Bank of CanadaLower TargetOutperform$260.00 ➝ $215.00
10/29/2021Wells Fargo & CompanyBoost TargetOverweight$156.00 ➝ $165.00
10/28/2021UBS GroupLower TargetNeutral$142.00 ➝ $135.00
10/28/2021Bank of AmericaLower TargetNeutral$175.00 ➝ $160.00
10/28/2021Craig HallumLower TargetHold$165.00 ➝ $150.00
10/28/2021Cantor FitzgeraldLower TargetNeutral$185.00 ➝ $150.00
10/28/2021Needham & Company LLCLower TargetBuy$205.00 ➝ $170.00
10/28/2021OppenheimerLower TargetMarket Perform ➝ Outperform$220.00 ➝ $200.00
10/28/2021BTIG ResearchLower TargetBuy$260.00 ➝ $210.00
10/28/2021BarclaysLower TargetEqual Weight$170.00 ➝ $150.00
10/28/2021CitigroupLower TargetBuy$225.00 ➝ $190.00
10/28/2021Piper SandlerLower TargetBuy ➝ Overweight$291.00 ➝ $183.00
10/28/2021Leerink PartnersLower TargetPositive ➝ Outperform$218.00 ➝ $205.00
10/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$156.00
8/9/2021CowenLower TargetOutperform$240.00 ➝ $188.00
8/2/2021ArgusDowngradeBuy ➝ Hold
7/29/2021Leerink PartnersReiterated RatingBuy
7/28/2021BTIG ResearchLower TargetBuy$300.00 ➝ $260.00
7/28/2021Craig HallumLower TargetIn-Line ➝ Hold$202.00 ➝ $165.00
7/28/2021KeyCorpLower TargetOverweight$220.00 ➝ $180.00
7/28/2021Leerink PartnersLower TargetOutperform$266.00 ➝ $218.00
7/28/2021Needham & Company LLCLower TargetBuy$235.00 ➝ $205.00
7/28/2021OppenheimerLower TargetMarket Perform ➝ Outperform$250.00 ➝ $220.00
7/28/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$225.00 ➝ $153.00
7/28/2021CitigroupLower TargetIn-Line ➝ Buy$260.00 ➝ $225.00
7/28/2021BarclaysLower TargetEqual Weight$240.00 ➝ $170.00
5/27/2021Robert W. BairdInitiated CoverageNeutral$162.00
5/10/2021Truist FinancialLower Target$275.00 ➝ $206.00
4/30/2021Credit Suisse GroupLower TargetOutperform$300.00 ➝ $264.00
4/29/2021OppenheimerLower Target$270.00 ➝ $250.00
4/29/2021Craig HallumLower TargetHold$220.00 ➝ $202.00
4/29/2021BTIG ResearchLower TargetBuy$330.00 ➝ $300.00
4/29/2021KeyCorpLower TargetOverweight$270.00 ➝ $220.00
4/15/2021Needham & Company LLCInitiated CoverageBuy$235.00
3/17/2021Deutsche Bank AktiengesellschaftLower TargetBuy$263.00 ➝ $226.00
2/26/2021Credit Suisse GroupBoost TargetOutperform$296.00 ➝ $300.00
2/25/2021William BlairReiterated RatingOutperform
2/25/2021Stifel NicolausLower Target$270.00 ➝ $234.00
2/25/2021DA DavidsonBoost TargetBuy$260.00 ➝ $275.00
2/25/2021OppenheimerBoost TargetOutperform$250.00 ➝ $270.00
2/25/2021Jefferies Financial GroupLower TargetHold$264.00 ➝ $248.00
2/25/2021Leerink PartnersBoost TargetOutperform$256.00 ➝ $266.00
2/25/2021KeyCorpBoost TargetOverweight$245.00 ➝ $270.00
2/25/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$244.00 ➝ $263.00
2/25/2021Piper SandlerLower TargetOverweight$305.00 ➝ $291.00
1/26/2021BTIG ResearchBoost TargetBuy$260.00 ➝ $330.00
1/12/2021BTIG ResearchBoost TargetBuy$240.00 ➝ $260.00
1/6/2021BTIG ResearchInitiated CoverageBuy$240.00
12/22/2020Evercore ISIInitiated CoverageIn-Line$215.00
12/17/2020Craig HallumBoost TargetPositive ➝ Hold$200.00 ➝ $212.00
12/7/2020StephensDowngradeOverweight ➝ Equal Weight$270.00 ➝ $210.00
12/4/2020The Goldman Sachs GroupInitiated CoverageNeutral$206.00
12/1/2020Bank of AmericaReiterated RatingHold ➝ Neutral$245.00
11/13/2020Robert W. BairdUpgradeNeutral ➝ Outperform$220.00
11/11/2020Truist FinancialLower Target$282.00 ➝ $252.00
10/29/2020Wells Fargo & CompanyBoost TargetEqual Weight$175.00 ➝ $200.00
10/29/2020Leerink PartnersBoost TargetOutperform$246.00 ➝ $256.00
10/29/2020Deutsche Bank AktiengesellschaftBoost TargetPositive ➝ Buy$239.00 ➝ $244.00
10/29/2020KeyCorpBoost TargetOverweight$240.00 ➝ $245.00
10/28/2020Piper SandlerBoost Target$232.00 ➝ $305.00
9/22/2020DA DavidsonInitiated CoverageBuy$250.00
9/8/2020OppenheimerBoost TargetOutperform$84.00 ➝ $250.00
9/4/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$225.00 ➝ $239.00
9/2/2020Berenberg BankUpgradeHold ➝ Buy$252.00
8/21/2020Royal Bank of CanadaBoost Target$235.00 ➝ $260.00
8/17/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$225.00 ➝ $249.00
8/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$238.00 ➝ $225.00
8/6/2020Truist FinancialUpgradeHold ➝ Buy$282.00
7/30/2020Wells Fargo & CompanyBoost Target$135.00 ➝ $175.00
7/30/2020Stifel NicolausBoost TargetHold$144.00 ➝ $205.00
7/30/2020JPMorgan Chase & Co.Boost TargetOverweight$240.00 ➝ $266.00
7/30/2020Credit Suisse GroupBoost TargetNeutral$165.00 ➝ $225.00
7/30/2020Leerink PartnersBoost TargetOutperform$227.00 ➝ $246.00
7/30/2020Royal Bank of CanadaBoost TargetOutperform$200.00 ➝ $235.00
7/30/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$184.00 ➝ $238.00
7/30/2020Cantor FitzgeraldBoost TargetNeutral$165.00 ➝ $210.00
7/30/2020BarclaysBoost TargetEqual Weight$200.00 ➝ $230.00
7/30/2020Piper SandlerBoost TargetOverweight$220.00 ➝ $232.00
7/30/2020KeyCorpBoost TargetOverweight$195.00 ➝ $240.00
7/17/2020BarclaysBoost TargetEqual Weight$180.00 ➝ $200.00
7/15/2020JPMorgan Chase & Co.Boost TargetOverweight$194.00 ➝ $240.00
7/14/2020CitigroupInitiated CoverageBuy$275.00
7/13/2020ArgusInitiated CoverageBuy$280.00
7/8/2020CowenReiterated RatingBuy$197.00
7/6/2020StephensInitiated CoverageOverweight$250.00
7/6/2020Leerink PartnersBoost TargetOutperform$197.00 ➝ $227.00
6/30/2020Piper SandlerReiterated RatingBuy$220.00
6/30/2020Royal Bank of CanadaReiterated RatingBuy
6/5/2020Piper SandlerBoost TargetOverweight$212.00 ➝ $220.00
5/27/2020Royal Bank of CanadaReiterated RatingOutperform$200.00
5/13/2020SunTrust BanksBoost TargetHold$144.00 ➝ $200.00
5/1/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$172.00 ➝ $184.00
4/30/2020CSFBBoost TargetNeutral$152.00 ➝ $165.00
4/30/2020Royal Bank of CanadaBoost TargetIn-Line ➝ Outperform$150.00 ➝ $200.00
4/30/2020Credit Suisse GroupBoost TargetNeutral$152.00 ➝ $165.00
4/30/2020Piper SandlerBoost Target$193.00 ➝ $212.00
4/30/2020UBS GroupBoost TargetNeutral$119.00 ➝ $185.00
4/30/2020JPMorgan Chase & Co.Boost TargetOverweight$182.00 ➝ $194.00
4/30/2020Craig HallumBoost TargetHold$140.00 ➝ $150.00
4/30/2020Cantor FitzgeraldBoost TargetNeutral$145.00 ➝ $165.00
4/30/2020CowenBoost TargetOutperform$175.00 ➝ $197.00
4/30/2020KeyCorpBoost TargetOverweight$180.00 ➝ $195.00
4/30/2020Stifel NicolausBoost TargetHold$135.00 ➝ $144.00
4/30/2020Leerink PartnersBoost TargetOutperform$180.00 ➝ $197.00
4/30/2020BarclaysReiterated RatingHold$140.00 ➝ $180.00
4/16/2020Wells Fargo & CompanyBoost TargetEqual Weight$105.00 ➝ $135.00
4/15/2020Robert W. BairdBoost TargetNeutral$130.00 ➝ $135.00
4/15/2020SunTrust BanksBoost TargetHold$118.00 ➝ $144.00
4/15/2020JPMorgan Chase & Co.Boost TargetOverweight$164.00 ➝ $182.00
4/15/2020Deutsche Bank AktiengesellschaftLower TargetBuy$179.00 ➝ $172.00
4/15/2020Piper SandlerBoost TargetOverweight$142.00 ➝ $193.00
4/15/2020CowenBoost TargetPositive ➝ Outperform$150.00 ➝ $175.00
4/15/2020KeyCorpBoost TargetOverweight$145.00 ➝ $180.00
4/15/2020Cantor FitzgeraldBoost TargetNeutral$135.00 ➝ $145.00
4/13/2020Leerink PartnersInitiated CoverageOutperform$180.00
4/6/2020Credit Suisse GroupBoost TargetNeutral$137.00 ➝ $152.00
4/2/2020Deutsche Bank AktiengesellschaftLower TargetBuy$179.00
(Data available from 4/1/2020 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 8 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
Mentions as of
9/3/2024
  • 17 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/3/2024
  • 8 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/2/2024
  • 11 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/2/2024
  • 15 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/1/2025
  • 10 very positive mentions
  • 14 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2025
  • 21 very positive mentions
  • 35 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
3/2/2025
  • 27 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2025

Current Sentiment

  • 27 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Teladoc Health logo
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Read More

Today's Range

Now: $7.77
Low: $7.69
High: $8.09

50 Day Range

MA: $10.29
Low: $7.77
High: $14.36

52 Week Range

Now: $7.77
Low: $6.76
High: $15.21

Volume

6,165,768 shs

Average Volume

6,191,416 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of Teladoc Health?

The following equities research analysts have issued research reports on Teladoc Health in the last year: Bank of America Co., Barclays PLC, Canaccord Genuity Group Inc., Cantor Fitzgerald, DA Davidson, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for TDOC.

What is the current price target for Teladoc Health?

0 Wall Street analysts have set twelve-month price targets for Teladoc Health in the last year. Their average twelve-month price target is $11.26, suggesting a possible upside of 45.0%. Canaccord Genuity Group Inc. has the highest price target set, predicting TDOC will reach $17.00 in the next twelve months. DA Davidson has the lowest price target set, forecasting a price of $8.00 for Teladoc Health in the next year.
View the latest price targets for TDOC.

What is the current consensus analyst rating for Teladoc Health?

Teladoc Health currently has 11 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TDOC, but not buy more shares or sell existing shares.
View the latest ratings for TDOC.

What other companies compete with Teladoc Health?

Other companies that are similar to Teladoc Health include Guardant Health, RadNet, Sotera Health, BrightSpring Health Services and Surgery Partners. Learn More about companies similar to Teladoc Health.

How do I contact Teladoc Health's investor relations team?

Teladoc Health's physical mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider's listed phone number is (203) 635-2002 and its investor relations email address is teladoc@westwicke.com. The official website for Teladoc Health is www.teladochealth.com. Learn More about contacing Teladoc Health investor relations.